In June 2015, Health Canada’s new guidance for the review and submission of drug brand names went into effect bringing with it significant changes in how your drug brand names will be reviewed, and the responsibilities of the drug manufacturers in this new process.
To learn more about these changes and how this will impact your preparations to launch a product in Canada download Addison Whitney Health’s webinar where we cover:
- Overview of the regulatory changes
- New steps involved in the process: Search, Simulate and Synthesize
- Name preparation & submission process
- FAQ’s about Health Canada’s changes
Download the video here: http://bit.ly/1e0tBEd